Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
How effective is duloxetine Cymbalta for CIPN (chemotherapy-induced peripheral neuropathy)? The good news is that, according to the research below, cymbalta reduced pain in CIPN more than the placebo did.
The bad news is that the risk of side effects can be problematic for the MM patient. Let me explain.
According to research, %20-40% of MM patients present with kidney involvement at diagnosis. And up to 50% of MM die from kidney failure.
So when I see an article citing kidney damage as a side effect of a pain therapy for a common side effect of MM treatment, I will blog about it.
Which FDA approved therapies for the treatment of multiple myeloma can damage kidney health?
2. Immunomodulatory Drugs (IMiDs)
3. Alkylating Agents
4. Corticosteroids (Dexamethasone, Prednisone)
5. Bisphosphonates (for bone disease in multiple myeloma)
In my experience as a myeloma patient, oncology does a poor job of explaining possible side effects and rarely if ever offers non-conventional, non-FDA approved therapies.
Email me at David.PeopleBeatingCancer@gmail.com with your questions about your MM, side effects, etc.
Thank you,
David Emerson
Objective- The primary objective was to determine the effect of duloxetine 60 mg daily on CIPN “average” pain severity…
Intervention-The initial treatment consisted of duloxetine/placebo 30mg/one capsule daily for the first week, then 60mg/two capsules for four additional weeks…
Results- Individuals receiving duloxetine as initial treatment (weeks 1–5) reported a larger mean decrease in average pain (1.06; 95% CI: 0.72, 1.40) compared to placebo-treated patients (0.34; 95% CI: 0.01, 0.66) (p = 0.003) (effect size = 0.513). The observed mean difference in the average pain score between the duloxetine and placebo groups was 0.73 (95% CI: 0.26, 1.20). 59% of duloxetine-treated patients compared to 38% of placebo-treated patients reported decreased pain of any amount.
Conclusions-Among patients with painful CIPN, the use of duloxetine compared with placebo for 5 weeks resulted in a greater reduction in pain…
Approximately 20–40% of patients with cancer who receive neurotoxic chemotherapy (e.g., taxanes, platinums, vinca alkaloids, bortezomib) will develop painful chemotherapy-induced peripheral neuropathy (CIPN).1–3 Painful CIPN can persist from months to years beyond chemotherapy completion, causing significant challenges for cancer survivors due to negative influence on function and quality of life (QOL).4–8…
Duloxetine belongs to a group of medicines called serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amount of natural chemicals or neurotransmitters called serotonin and norepinephrine in the brain…
The most common side effects of duloxetine are listed below. Tell your healthcare provider if you have any of these side effects that bother you…
While less common, the most serious side effects of duloxetine are described below, along with what to do if they happen…
Liver Damage. Liver damage, also called hepatotoxicity, can happen when taking duloxetine. Stop taking duloxetine and call your healthcare provider right away if you have any of the following symptoms of liver damage…
Kidney Problems. Duloxetine should not be used if your kidneys are not working as well as they should be. If there is a concern about the health of your kidneys, your healthcare provider may do tests to determine if they are working well enough to take this medicine.
Liver Problems. Duloxetine should not be used if your liver is not working as well as it should be. If there is a concern about the health of your liver, your healthcare provider may do tests to determine if it is working well enough to take this medicine.